Clinical implications of patent foramen ovale in migraine with aura

Pasquale Marchione1, Natascia Ghiotto, Grazia Sances

  • 1Neurovascular Unit, Department of Neurology and Otorhinolaringology, University La Sapienza, Rome, Italy.

Functional Neurology
|April 1, 2009
PubMed

Insights

Patent foramen ovale (PFO) is more common in migraine with aura (MWA) patients, especially those with atypical aura features. This finding suggests PFO screening may be beneficial for MWA patients with unusual symptoms.

Area of Science:

  • Neurology
  • Cardiology
  • Vascular Medicine

Background:

  • Patent foramen ovale (PFO) is frequently observed in patients experiencing migraine with aura (MWA).
  • The specific relationship between PFO and the characteristics of aura symptoms, as well as its impact on stroke risk, requires further investigation.

Purpose of the Study:

  • To investigate the association between patent foramen ovale (PFO) and the specific features of aura in patients diagnosed with migraine with aura (MWA).
  • To assess the relative impact of the PFO-MWA association on stroke risk.

Main Methods:

  • Patients diagnosed with MWA were enrolled and assessed for PFO using contrast transcranial Doppler and transoesophageal echocardiography.
  • Participants were categorized into two groups based on aura characteristics: typical (Group 1) and atypical (Group 2).

Main Results:

  • A significantly higher prevalence of PFO was observed in patients with atypical aura features (79.2%) compared to those with typical aura features (46.3%) (p=0.009).
  • No significant differences were found in the prevalence of traditional stroke risk factors or thrombophilic markers between the groups.

Conclusions:

  • The study highlights the importance of screening for PFO in MWA patients, particularly those presenting with atypical aura symptoms.
  • The underlying pathophysiological mechanisms connecting PFO and atypical aura features remain unclear and warrant further research.

Related Concept Videos

Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...